ALL-HEART: No Benefit of Allopurinol in Ischemic Heart Disease ALL-HEART: No Benefit of Allopurinol in Ischemic Heart Disease
Allopurinol failed to affect a composite of nonfatal MI, nonfatal stroke, or CV death, in a randomized trial that was ' definitively neutral ' in patients with heart disease but no gout.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Cardiology News Source Type: news
More News: Allopurinol | Cardiology | Gout | Heart | Heart Disease | Internal Medicine | Ischemic Stroke | Stroke